Roger F Butterworth

Summary

Country: Canada

Publications

  1. Butterworth R, Norenberg M, Felipo V, Ferenci P, Albrecht J, Blei A. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int. 2009;29:783-8 pubmed publisher
    ..More attention could be paid in the future to in vitro models involving the neurovascular unit, microglia and neuronal co-cultures in relation to HE pathogenesis. ..
  2. Butterworth R. Reprint of: Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets. Neurochem Int. 2012;60:715-22 pubmed
    ..Translation of these findings to the clinic has the potential to provide rational targeted approaches to the prevention and treatment of these complications in the near future. ..
  3. Butterworth R. The concept of "the inflamed brain" in acute liver failure: mechanisms and new therapeutic opportunities. Metab Brain Dis. 2016;31:1283-1287 pubmed
    ....
  4. Butterworth R. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited. Metab Brain Dis. 2016;31:1211-1215 pubmed
    ....
  5. Butterworth R. Thiamine deficiency-related brain dysfunction in chronic liver failure. Metab Brain Dis. 2009;24:189-96 pubmed publisher
    ..These findings underscore the need for prompt, effective thiamine supplementation in all patients with chronic liver failure. ..
  6. Butterworth R. Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology. 2011;53:1372-6 pubmed publisher
    ..The prevention of central proinflammatory processes will undoubtedly herald a new chapter in the development of agents for the prevention and treatment of the central nervous system complications of liver failure. ..
  7. Butterworth R. Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets. Neurochem Int. 2011;59:830-6 pubmed publisher
    ..Translation of these findings to the clinic has the potential to provide rational targeted approaches to the prevention and treatment of these complications in the near future. ..

Detail Information

Publications7

  1. Butterworth R, Norenberg M, Felipo V, Ferenci P, Albrecht J, Blei A. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int. 2009;29:783-8 pubmed publisher
    ..More attention could be paid in the future to in vitro models involving the neurovascular unit, microglia and neuronal co-cultures in relation to HE pathogenesis. ..
  2. Butterworth R. Reprint of: Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets. Neurochem Int. 2012;60:715-22 pubmed
    ..Translation of these findings to the clinic has the potential to provide rational targeted approaches to the prevention and treatment of these complications in the near future. ..
  3. Butterworth R. The concept of "the inflamed brain" in acute liver failure: mechanisms and new therapeutic opportunities. Metab Brain Dis. 2016;31:1283-1287 pubmed
    ....
  4. Butterworth R. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited. Metab Brain Dis. 2016;31:1211-1215 pubmed
    ....
  5. Butterworth R. Thiamine deficiency-related brain dysfunction in chronic liver failure. Metab Brain Dis. 2009;24:189-96 pubmed publisher
    ..These findings underscore the need for prompt, effective thiamine supplementation in all patients with chronic liver failure. ..
  6. Butterworth R. Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology. 2011;53:1372-6 pubmed publisher
    ..The prevention of central proinflammatory processes will undoubtedly herald a new chapter in the development of agents for the prevention and treatment of the central nervous system complications of liver failure. ..
  7. Butterworth R. Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets. Neurochem Int. 2011;59:830-6 pubmed publisher
    ..Translation of these findings to the clinic has the potential to provide rational targeted approaches to the prevention and treatment of these complications in the near future. ..